Rokitamycin

rokitamycin.png

Rokitamycin is a macrolide antibiotic used in the treatment of various bacterial infections. It is derived from the bacterium Streptomyces kitasatoensis. Rokitamycin is known for its effectiveness against a range of Gram-positive bacteria and some Gram-negative bacteria.

Mechanism of Action[edit]

Rokitamycin works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, thereby preventing the translocation of peptides. This action effectively halts bacterial growth and replication, making it a bacteriostatic antibiotic.

Pharmacokinetics[edit]

Rokitamycin is absorbed from the gastrointestinal tract and reaches peak plasma concentrations within a few hours of oral administration. It is metabolized in the liver and excreted primarily through the bile and, to a lesser extent, the urine.

Clinical Uses[edit]

Rokitamycin is used to treat a variety of infections, including:

Side Effects[edit]

Common side effects of rokitamycin include:

Less common but more serious side effects can include:

Contraindications[edit]

Rokitamycin should not be used in patients with a known hypersensitivity to macrolide antibiotics. Caution is advised in patients with liver disease or cardiac conditions.

Drug Interactions[edit]

Rokitamycin can interact with other medications, including:

These interactions can lead to increased levels of the co-administered drugs, necessitating dose adjustments and careful monitoring.

History[edit]

Rokitamycin was first isolated and characterized in the late 20th century. It has since been used in various countries for the treatment of bacterial infections, although its use may be limited compared to other macrolides like erythromycin and azithromycin.

References[edit]

This medical article is a stub. You can help WikiMD by expanding the page.